Evidence map›Paper›PMID 38623146›Full record

ArticleInternational journal of clinical and health psychology : IJCHP

MIR137 polygenic risk for schizophrenia and ephrin-regulated pathway: Role in lateral ventricles and corpus callosum volume.

G A M Blokland, N Maleki, J Jovicich, R I Mesholam-Gately, L E DeLisi, J A Turner, M E Shenton, A N Voineskos, R S Kahn, J L Roffman and 44 more

Open access · goldAbstract read
In one paragraph

Article in International journal of clinical and health psychology : IJCHP. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. The Eph-ephrin system in neuropsychiatric and neurodevelopmental disorders.Journal of psychiatry & neuroscience : JPN · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

54 authors at 20 institutions in 10 countries.

G A M BloklandDepartment of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Faculty of Health, Medicine, and Life Sciences, Maastricht University, Netherlands.
N MalekiMGH/HST Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, United States.
J JovicichCenter for Mind/Brain Sciences (CIMeC), University of Trento, Trento, Italy.
R I Mesholam-GatelyMassachusetts Mental Health Center Public Psychiatry Division, Beth Israel Deaconess Medical Center, Boston, MA, United States.
L E DeLisiDepartment of Psychiatry, Cambridge Health Alliance, Cambridge, MA, United States.
J A TurnerDepartment of Psychiatry and Behavioral Health, The Ohio State University, Columbus, OH, United States.
M E ShentonPsychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, United States.
A N VoineskosKimel Family Translational Imaging Genetics Laboratory, Department of Psychiatry, Research Imaging Centre, Campbell Family Mental Health Institute, Centre for Addiction and Mental Health, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
R S KahnBrain Centre Rudolf Magnus, Department of Psychiatry, University Medical Centre Utrecht, Utrecht, The Netherlands.
J L RoffmanDepartment of Psychiatry, Harvard Medical School, Boston, MA, United States.
D J HoltDepartment of Psychiatry, Harvard Medical School, Boston, MA, United States.
S EhrlichDivision of Psychological & Social Medicine and Developmental Neurosciences, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Z KikinisPsychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, United States.
P DazzanInstitute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.
R M MurrayInstitute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.
J LeeInstitute of Mental Health, Woodbridge Hospital, Singapore.
K SimInstitute of Mental Health, Woodbridge Hospital, Singapore.
M LamStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, United States.
S M C de ZwarteBrain Centre Rudolf Magnus, Department of Psychiatry, University Medical Centre Utrecht, Utrecht, The Netherlands.
E WaltonDepartment of Psychology, University of Bath, Bath, United Kingdom.
S KellyNeuropsychiatric Genetics Research Group, Department of Psychiatry, Institute of Molecular Medicine, Trinity College Dublin, Dublin, Ireland.
M M PicchioniInstitute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.
E BramonInstitute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.
N MakrisMGH/HST Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, United States.
A S DavidDivision of Psychiatry, University College London, London, United Kingdom.
V MondelliInstitute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.
A A T S ReindersInstitute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.
E OykhmanMassachusetts Mental Health Center Public Psychiatry Division, Beth Israel Deaconess Medical Center, Boston, MA, United States.
D W MorrisCognitive Genetics and Cognitive Therapy Group, Neuroimaging and Cognitive Genomics (NICOG) Centre and NCBES Galway Neuroscience Centre, School of Psychology and Discipline of Biochemistry, National University of Ireland, Galway, Ireland.
M GillNeuropsychiatric Genetics Research Group, Department of Psychiatry, Institute of Molecular Medicine, Trinity College Dublin, Dublin, Ireland.
A P CorvinNeuropsychiatric Genetics Research Group, Department of Psychiatry, Institute of Molecular Medicine, Trinity College Dublin, Dublin, Ireland.
W CahnBrain Centre Rudolf Magnus, Department of Psychiatry, University Medical Centre Utrecht, Utrecht, The Netherlands.
N HoInstitute of Mental Health, Woodbridge Hospital, Singapore.
J LiuGenome Institute, Singapore.
R L GollubMGH/HST Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, United States.
D S ManoachMGH/HST Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, United States.
V D CalhounTri-institutional Center for Translational Research in Neuroimaging and Data Science (TReNDS), Georgia State, Georgia Tech, Emory, Atlanta, GA, United States.
S R SponheimDepartment of Psychiatry, University of Minnesota, Minneapolis, MN, United States.
S L BukaDepartment of Epidemiology, Brown University, Providence, RI, United States.
S CherkerzianDepartment of Medicine, Division of Women's Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
H W ThermenosMassachusetts Mental Health Center Public Psychiatry Division, Beth Israel Deaconess Medical Center, Boston, MA, United States.
E W DickieKimel Family Translational Imaging Genetics Laboratory, Department of Psychiatry, Research Imaging Centre, Campbell Family Mental Health Institute, Centre for Addiction and Mental Health, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
S CiufoliniInstitute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.
T Reis MarquesInstitute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.
N A CrossleyInstitute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.
S M PurcellDepartment of Psychiatry, Brigham and Women's Hospital, Boston, MA, United States.
J W SmollerPsychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, United States.
N E M van HarenDepartment of Child and Adolescent Psychiatry/Psychology, Erasmus Medical Centre, Rotterdam, The Netherlands.
T ToulopoulouDepartment of Psychology & National Magnetic Resonance Research Center (UMRAM), Aysel Sabuncu Brain Research Centre (ASBAM), Bilkent University, Ankara, Turkey.
G DonohoeCognitive Genetics and Cognitive Therapy Group, Neuroimaging and Cognitive Genomics (NICOG) Centre and NCBES Galway Neuroscience Centre, School of Psychology and Discipline of Biochemistry, National University of Ireland, Galway, Ireland.
J M GoldsteinDepartment of Psychiatry, Harvard Medical School, Boston, MA, United States.
M S KeshavanMassachusetts Mental Health Center Public Psychiatry Division, Beth Israel Deaconess Medical Center, Boston, MA, United States.
T L PetryshenPsychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, United States.
E C Del ReMassachusetts Mental Health Center Public Psychiatry Division, Beth Israel Deaconess Medical Center, Boston, MA, United States.
King's College London · GBHarvard University · USBeth Israel Deaconess Medical Center · USBroad Institute · USBrigham and Women's Hospital · USUniversity Medical Center Utrecht · NLCentre for Addiction and Mental Health · CAInstitute of Mental Health · SGTrinity College Dublin · IEBilkent University · TRBrown University · USCambridge Health Alliance · USGeorgia Institute of Technology · USOllscoil na Gaillimhe – University of Galway · IETechnische Universität Dresden · DEThe Ohio State University · USUniversity College London · GBUniversity of Bath · GBUniversity of Minnesota · USUniversity of Southern California · US

Funding

Genetic Determinants of Schizophrenia Intermediate PhenotypesR01MH092380 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI PETRYSHEN, TRACEY · 2012 to 2015
$2.4M
VENTRICLES, CORPUS CALLOSUM, SYMPTOMS & MIR137 IN LARGE N STUDY OF SCHIZOPHRENIAR21MH109819 · NIMH · HARVARD MEDICAL SCHOOL · PI DEL RE, ELISABETTA C. · 2016 to 2017
$431k
NIMH NIH HHS R01 MH092380NIMH NIH HHS R21 MH109819
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Corpus callosumEphrin pathwayLateral ventriclesMIR137Polygenic risk scoreSchizophrenia

Identifiers

PMID38623146
PMCPMC11017057
OpenAlexW4394622958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.